- Research article
- Open Access
Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study
BMC Ophthalmology volume 10, Article number: 13 (2010)
Ethnic, intersubject, interoperator and intermachine differences in measured macular thickness seem to exist. Our purpose was to collect normative macular thickness data in Norwegians and to evaluate the association between macular thickness and age, gender, parity, and contraception status.
Retinal thickness was measured by Stratus Optical Coherence Tomography in healthy subjects. Mean macular thickness (MMT) was analyzed by repeated measures ANOVA with three dependent regional MMT-variables for interaction with age, gender, parity and oral contraception use. Exploratory correlation with age by the Pearson correlation test, both before and after stratification by gender was performed. Differences in MMT between older and younger subjects, between oral contraception users and non-users, as well as parous and nulliparous women were studied by post-hoc Student's t-tests.
Central MMT in Norwegians was similar to values earlier reported in whites. MMT in central areas of 1 and 2.25 mm in diameter were higher in males than in females. In younger subjects (≤43 years) differences in MMT between genders were larger than in the mixed age group, whereas in older subjects (>43 years) the small differences did not reach the set significance level. No differences were found in minimal foveolar thickness (MMFT) between the genders in any age group.
Mean foveal thickness (1 mm in diameter) was positively associated with age in females (r = 0.28, p = 0.03). MMFT was positively associated with age in all groups and reached significance both in females and in mixed gender group (r = 0.20, p = 0.041 and r = 0.26, p = 0.044 respectively).
Mean foveal thickness and MMFT were significantly higher in parous than in nulliparous women, and age-adjusted ANOVA for MMFT revealed a borderline effect of parity.
Age and gender should be taken into consideration when establishing normal ranges for MMT in younger subjects. The gender difference in retinal thickness in young, but not older adults suggests a gonadal hormonal influence. The possible association between parity and retinal structure and its clinical relevance, should be studied further.
In vivo qualitative and quantitative imaging of the retina by the optical coherence tomography (OCT)  is non-invasive, obtainable and reproducible even on non-dilated eyes [2–4] in both healthy subjects and in patients with macular pathology [5, 6].
Macular aging involves alterations in its function, structure  and blood supply , which are partly induced by chronic low-grade inflammation . Complex multifactorial genetic and environmental factors may accelerate the aging process or trigger a progressive and irreversible loss of central vision , as in age-related macular degeneration [11, 12]. Some of these factors seem to be modulated by gonadal sex hormones [13–15].
Sex-related differences exist in both healthy and diseased eyes [16, 17], and several sight threatening retinal conditions like age-related macular degeneration and idiopathic macular holes have been associated with the female gender and reproductive history [18–20]. It has been suggested that the macula in females, being thinner, is more vulnerable than in males.
However, there is inconsistency as to whether mean macular thickness (MMT) varies with age and gender in published papers. Both gender specific sex hormones and age related hormonal changes in women are known to influence macular function [21, 22]. Although there is a growing body of evidence that estrogens influence maintenance of retinal function and integrity [23, 24], little is known about their effects on MMT measured by the OCT.
Ethnic differences exist in the prevalence of age-related macular degeneration , gonadal hormone levels in women  and in MMT [27–30], and may explain some of the variations in the published literature. Since the prevalence of early age-related maculopathy appears to be higher in the urban Norwegian population than in other populations  and that menopause possibly occur earlier in Norwegians (about 50 years) than in Europe (about 54 years) [32–35], we hypothesized that MMT measurements in Norwegians could differ from measurements in other populations. There are also intersubject, interoperator and intermachine variability in measured MMT, even when identical OCT versions are being used .
The purpose of the present study was to collect normative data on the Stratus OCT in Norwegians. We also assessed the effect of age, gender, parity and the use of oral contraception on macular thickness in our study sample.
Subjects were prospectively recruited from students and staff at St. Olavs University Hospital. Inclusion criteria were best corrected visual acuity (Humphery automatic refractor HARK 597, Dublin, CA) better than 0.8 with spheric equivalent of ±6, no current medical eye history (uncomplicated refractive surgery >2 years prior to enrollment was accepted), no evidence of pathology on slit lamp microscopy with 90-diopter lens, no significant lens opacities and normal intraocular pressure. Subjects with diabetes or systemic inflammatory conditions were not included.
Initially 258 phakic, healthy-appearing eyes of 129 subjects were included. Fifteen single eyes of 15 subjects were excluded because they applied diclofenac or dexamethasone topically for three days in one eye (parallel study). Eighteen subjects (bilateral scans) and 18 single eyes (of 16 subjects) were excluded due to low OCT signal, badly defined interfaces, alignment problems and/or missing data on the scan. Two subjects were excluded in spite of good OCT quality; one subject had eye symptoms with "foggy sight" despite normal eye examination, another had had heavy head trauma several years prior to examination.
Overall 185 OCT scans of 107 subjects, 78 bilateral and 29 unilateral were eligible for inclusion. Only one eye of each subject was included, laterality was randomly chosen (where bilateral scans were available).
All subjects gave their informed consent. The study was approved by the Regional Ethics Committee in May 2005. It was conducted in accordance with the Declaration of Helsinki recommendations. Subjects were included between September 2007 and September 2008.
Both eyes were examined and bilateral OCT (Optic Coherence Tomography STRATUS, Carl Zeiss Meditec, Inc., Dublin, CA) scans were obtained by a single operator on all eyes. Medical history was taken during the session, which included an optional interview about the use of hormonal contraception (44 of 62 women participated) and childbirth (57 of 62 women participated). If subjects consented to an extended examination, a multifocal electroretinography was also performed for future publications.
OCT was recorded in Macular Thickness Protocol (software v.5.0.1). Spherical values closest to subject's refraction were adjusted in the OCT, even though studies had shown that this did not affect macular thickness measurements significantly [2, 37]. A few myopic soft contact lens users were allowed to keep the correction on. The room was darkened to gain maximal undilated pupil size and volunteers were asked to gaze at the internal fixation mark within the OCT, while six radial retinal scans were taken.
The scans were obtained at equally spaced angular orientation centered on the foveola. MMT is generated by the OCT software algorithms by calculating the distance between the vitreoretinal interface and the boundary between the inner and outer photoreceptor segment in microns. Each 6 millimeter long scan takes measurements at 512 points, with higher density near the foveola. Mean macular thickness (MMT) is then calculated automatically and reported.
Pharmacological dilatation was not routinely applied, as it is not a necessary procedure for Stratus OCT [3, 4]. However, noisy scans were retaken after dilatation with tropicamide 0.5% one drop in each eye if subjects consented (after removing contact lenses). Eye movements, fixation losses and blinks prolonged the procedure, while undilated pupils  and soft contact lenses  deteriorated the signal strength. Barkana et al.  found that signal strength did not affect any measured MMT parameters when scans with signal strength ≥4 (out of maximum ten) were included (using the fast macular protocol) . Moreover, Muscat et al.  showed that even considerably degraded signal strength produced accurate, precise and reproducible MMT measurements.
Scans with well defined interfaces and signal strength better than three were included. Measured MMT could vary with axial length and refraction by altering the area measured in a scan, because the default axial length in the STRATUS OCT is set to 24.45 mm. A longer axial length and myopia results in axial magnification and a larger circle area would be measured . However, since peripheral MMT measurements are more susceptible to axial magnification than central , and there is high concordance in measured MMT in the central areas by the shorter (3.45 mm) and the longer (6 mm) scan length mapping protocols , the shorter (3.45 mm) scan length was chosen (even though no high myopes were included).
In this protocol the macula is divided into 9 areas: Mean foveal thickness (MFT = F1) from a central macular area of one millimeter in diameter, the inner ring (F2-F5) and the outer ring (F6-F9), each divided into four quadrants. The outer ring diameters measured 2.22 and 3.45 millimeters respectively. Regional variables MCT (mean central thickness) and MPT (mean peripheral thickness) were defined by averaging middle (MCT = (F2 + F3 + F4 + F5)/4) and outer (MPT = (F6 + F7 + F8 + F9)/4) ring data (Fig. 1). Mean total averaged macular thickness (MTT) was calculated by averaging the nine macular areas (F1 + F2 + F3 + F4 + F5 + F6 + F7 + F8 + F9)/9. The inner region (MFT = F1) and mean minimal foveolar thickness (MMFT = F0) were also analyzed.
Participants were categorized in 11 partly overlapping subgroups according to age, parity, gender and oral contraception use. Parity was defined by delivering a live-borne child, contraception users were defined by use of oral contraception for at least three month prior to inclusion. No pregnant women were included. These subgroups are described, together with their mean OCT signal strength in Table 1.
One OCT scan of each subject was included, laterality was randomly chosen if bilateral scans were available, so that equal amount of right (n = 54) and left (n = 53) eyes were included. Signal strength was 4 or 5 in 38 scans, 6 or 7 in 43 scans and 8 to 10 in 26 included scans. MMT in the above described macular areas were analyzed and compared between the groups.
Regional variables MFT, MCT and MPT were analyzed with repeated measures ANOVA with age as covariate and gender as the grouping factor. Within-subject factors were assessed with multivariate repeated measures analysis. In women we performed two additional ANOVAs, one with parity and another with contraception use as grouping factors.
The associations between MMFT (foveola), age and either gender, parity, or contraceptives were studied by three separate ANOVAs with MMFT as the dependent variable.
MMT was also explored for statistical association with age in three separate groups (all 107 subjects, male subgroup and female subgroup) with the Pearson correlation test for the five macular variables (MMFT, MFT, MCT, MPT and MTT).
MMT in these five macular regions was analyzed with independent sample Student's t-tests for differences between the genders in three different groups: comparing males with females, younger males with younger females and older males with older females. MMT in parous women was compared with nulliparous women, and oral contraception users were compared with non-users by the same tests.
Data were analyzed in SPSS 16. All tests were two-sided and a p-value < 0.05 was considered statistically significant.
Normal mean regional MMT-values are reported in Table 2. Males had higher MMT values than females in central macular regions except MMFT (Table 2). In repeated measures ANOVA gender did affect MMT significantly (p = 0.001; Table 3). Significant interaction between region and gender was found (p = 0.009; Table 3).
In repeated measures ANOVA age was not significantly associated with MMT, although we observed a trend when females were analyzed separately (p = 0.1); Table 3). In the exploratory correlation analysis of MMT, we found a small but significant positive correlation between MFT and age in females (r = 0.28 p = 0.03) (Table 4; Fig. 2), and between MMFT and age in both females (r = 0.26 p = 0.044) and mixed-gender group (r = 0.20 p = 0.041) (Table 4). However, r-values were generally small, explaining less than 8% of the variance.
Differences between the genders in all central MMT regions (except MMFT) were significant in younger subjects (Table 5; Fig. 3) and in mixed-age group (Table 2), measuring higher values in males. Differences in MMT were non-significant in older subjects (Table 5).
Age-adjusted ANOVA for MMFT revealed a borderline effect for parity (F = 3.5, p = 0.066). No significant interaction between region and parity was observed (Table 3). However, with post-hoc Studen's t-tests MMFT, and MFT were observed to be significantly higher in parous compared to nulliparous women (Table 6; Fig. 4). Differences in MMT between women with and without oral contraception were not found.
Our measurements of MMT in central macular areas are in good agreement with other studies conducted on the Stratus OCT in whites. MMFT (foveola) was 177(SD 20) and MFT (fovea) 209 (15) in the female group while Liew et al.  found thicknesses of 178(23) and 212(19) in same areas in females aged 17 - 50 years. Chamberlain et al.  reported MFT of 210.3 (21) in Australian whites aged 50-80 years and Chan et al.  reported foveal MMT of 212(20) in mixed gender group, which is similar to our measured MFT of 213(16) in the mixed gender group. Evaluation of exact MMT in the more peripheral areas is difficult unless the same scan length is being used. MMT measurements in Norwegians do not seem to differ from earlier reported data on the Stratus OCT in whites.
Normal aging seems to affect macular cone function  but not foveal cone density . Most [44, 45, 48–54] but not all [28, 55] studies on the OCT did not report an association between foveal thickness and age in mixed gender group, which is in agreement with our results for MMT. However, our data in Table 4 suggest an increase in foveolar thickness (MMFT) with increasing age, which also confirms Kashani et al.'s  observation.
How can an age-related increase in MMT be explained? Foveolar cones rely solely on choriocapillar circulation to satisfy their high metabolic demands, lacking retinal capillaries . Macular retinal  and foveolar choroidal microcirculation decline with age , which may impair the susceptible fovea preferentially faster [11, 57]. Also aging-related para-inflammatory responses  may increase interstitial volume by impairing the blood-retina barrier [9, 58], possibly resulting in higher MMT measured by the OCT.
Bjornsson  reported higher prevalence of early age- related maculopathy (EAMD) in Norwegians compared with other ethnic populations, which might suggest the age-related MFT increase we observed could be attributed to genetic or local environmental factors [30, 43, 51, 59, 60]. However, this is less likely because our MMT values were similar to those reported in other white ethnic groups. Moreover, we found that MFT did not increase with age in males as it did in females, suggesting that hormonal factors might explain the association between age and MMT.
Most OCT studies describe gender differences in MFT [28, 45, 48, 49, 53, 54] or in several macular areas [52, 55]. Only a few studies did not find gender differences in MMT [50, 61, 62]. We found gender differences in MMT in almost all macular areas in younger but not in older subjects, which suggest that the sexual dimorphism of the human retina may depend on gonadal hormone levels. Indeed, estrogen receptors seem to protect the retina against age-inflicted injury [23, 24], partly by inhibiting lipid peroxidation [15, 63, 64]. Exposure to endogenous oestrogens has been associated with lower risk for EAMD [18, 19], and exogenous estrogens seem to protect against late age-related degeneration . It may accordingly be speculated that subclinical age-related para-inflammation may accelerate with declining estrogen levels and possibly explain the age-related MFT increase on the OCT in women.
Parity seems to lower estrogen levels in parous premenopausal compared with nulliparous women , partly by altering the sensitivity to sex hormones [66, 67]. Reproductive history factors like long and/or irregular menstrual cycles, early menopause, pregnancy losses and multiparity are associated with higher risk for cardiovascular disease . Hence, the trend towards an association between MMT and parity (Table 6) can possibly be related to a combination of hormonal and cardiovascular risk factors.
Why did we not find any effect of contraceptives on MMT? In the present study contraception use was defined by as a regular oral intake for at least three months prior to inclusion. Neither type of oral contraceptives nor their cumulative time of use were registered. We did not ask about the interdependendt factors as hormonal replacement therapy use, menopause, number of years from last pregnancy, lost pregnancies and multiparity. It is accordingly possible that a biologially relevant effect of oral contraceptives on MMT could have been demonstrated in a larger study with a suitable for this purpose design. Anyway, it should be noted that rather short-lasting current use of contraceptives did not seem to affect retinal thickness.
To make participation in our study convenient, a few younger myopic subjects kept their contact lenses on during the OCT measurement. This could have affected the measured MMT. Youm et al.  found a small increase (1.4 μ (SD 0.5)) in measured retinal nerve fiber layer (RNFL) (using Fast Protocol) when contacts were removed. However, this small effect is less than 2% of the MMT. In addition, RNFL measurements, unlike MMT measurements, are very susceptible to low scan quality (signal- to noise ratio and signal strength) [69, 70]. Hence, we believe that the potential effect of contact lens use during our measurement of MMT is very small if at all present. However, we can not exclude the possibility of a small contact lens effect, and also this topic should be addressed in a future study.
OCT measurements in healthy Norwegians did not differ from measurements in other whites. Differences in MMT between the genders in younger but not in older subjects were observed. Minimal foveolar thickness in both genders and female's foveal thickness were positively associated with increasing age, while a trend towards an effect of parity on central MMT was revealed. Age and gender should be taken into consideration when establishing normal ranges for MMT in younger subjects. Further studies are needed in women to increase our understanding of the possible association between MMT, parity, aging and hormonal status.
van Velthoven ME, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD: Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res. 2007, 26 (1): 57-77. 10.1016/j.preteyeres.2006.10.002.
Koozekanani D, Roberts C, Katz SE, Herderick EE: Intersession repeatability of macular thickness measurements with the humphrey 2000 oct. Invest Ophthalmol Vis Sci. 2000, 41 (6): 1486-1491.
Paunescu LA, Schuman JS, Price LL, Stark PC, Beaton S, Ishikawa H, Wollstein G, Fujimoto JG: Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using stratusoct. Invest Ophthalmol Vis Sci. 2004, 45 (6): 1716-1724. 10.1167/iovs.03-0514.
Hsu SY, Tsai RK: Analysis of retinal nerve fiber layer and macular thickness measurements in healthy taiwanese individuals using optical coherence tomography (stratus oct). J Glaucoma. 2008, 17 (1): 30-35. 10.1097/IJG.0b013e31811243b4.
Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A: Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 2001, 119 (8): 1135-1142.
Polito A, Del Borrello M, Isola M, Zemella N, Bandello F: Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol. 2005, 123 (10): 1330-1337. 10.1001/archopht.123.10.1330.
Bonnel S, Mohand-Said S, Sahel JA: The aging of the retina. Exp Gerontol. 2003, 38 (8): 825-831. 10.1016/S0531-5565(03)00093-7.
Grunwald JE, Piltz J, Patel N, Bose S, Riva CE: Effect of aging on retinal macular microcirculation: A blue field simulation study. Invest Ophthalmol Vis Sci. 1993, 34 (13): 3609-3613.
Xu HP, Chen M, Forrester JV: Para-inflammation in the aging retina. Prog Retin Eye Res. 2009, 28 (5): 348-368. 10.1016/j.preteyeres.2009.06.001.
Kaur I, Ghanekar Y, Chakrabarti S: Understanding the genetics of age-related macular degeneration: Some insights into the disease pathogenesis. International Journal of Human Genetics. 2008, 8 (1-2): 161-169.
Penfold PL, Madigan MC, Gillies MC, Provis JM: Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001, 20 (3): 385-414. 10.1016/S1350-9462(00)00025-2.
Ting AYC, Lee TKM, MacDonald IM: Genetics of age-related macular degeneration. Curr Opin Ophthalmol. 2009, 20 (5): 369-376. 10.1097/ICU.0b013e32832f8016.
Deschenes MC, Descovich D, Moreau M, Granger L, Kuchel GA, Mikkola TS, Fick GH, Chemtob S, Vaucher E, Lesk MR: Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci. 2010, 51 (5): 2587-600. 10.1167/iovs.09-3710.
Velez DR, Gallins P, Polk M, Ayala-Haedo J, Schwartz SG, Kovach JL, Spencer KM, Wang G, Agarwal A, Postel E, et al: Inverse association of female hormone replacement therapy and oral contraceptive use with age-related macular degeneration and interactions with arms2 polymorphisms. Invest Ophthalmol Vis Sci. 2010, 51 (4): 1873-1879. 10.1167/iovs.09-4000.
Dincer Y, Ozen E, Kadioglu P, Hatemi H, Akcay T: Effect of sex hormones on lipid peroxidation in women with polycystic ovary syndrome, healthy women, and men. Endocr Res. 2001, 27 (3): 309-316. 10.1081/ERC-100106008.
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, Willett WC: A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in u.S. Men. J Natl Cancer Inst. 1994, 86 (3): 183-191. 10.1093/jnci/86.3.183.
Gupta PD, Johar K, Nagpal K, Vasavada AR: Sex hormone receptors in the human eye. Surv Ophthalmol. 2005, 50 (3): 274-284. 10.1016/j.survophthal.2005.02.005.
Smith W, Mitchell P, Wang JJ: Gender, oestrogen, hormone replacement and age-related macular degeneration. Results from the blue mountains eye study. Aust N Z J Ophthalmol. 1997, 25: S13-S15. 10.1111/j.1442-9071.1997.tb01745.x.
Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE: Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol. 2008, 126 (4): 519-524. 10.1001/archopht.126.4.519.
Evans JR, Schwartz SD, McHugh JDA, Thamby-Rajah Y, Hodgson SA, Wormald RPL, Gregor ZJ: Systemic risk factors for idiopathic macular holes: A case-control study. Eye. 1998, 12: 256-259.
Eisner A, Toomey MD: The color appearance of stimuli detected via short-wavelength-sensitive cones: Comparisons with visual adaptation and visual field data for peri- or post-menopausal women under 70 years of age. Vision Res. 2008, 48 (26): 2663-2672. 10.1016/j.visres.2008.01.029.
Jagle H, Heine J, Kurtenbach A: L:M-cone ratio estimates of the outer and inner retina and its impact on sex differences in erg amplitudes. Doc Ophthalmol. 2006, 113 (2): 105-113. 10.1007/s10633-006-9019-8.
Elliot S, Catanuto P, Fernandez P, Espinosa-Heidmann D, Karl M, Korach K, Cousins SW: Subtype specific estrogen receptor action protects against changes in mmp-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res. 2008, 86 (4): 653-660. 10.1016/j.exer.2008.01.010.
Elliot SJ, Catanuto P, Espinosa-Heidmann DG, Fernandez P, Hernandez E, Saloupis P, Korach K, Karl M, Cousins SW: Estrogen receptor beta protects against in vivo injury in rpe cells. Exp Eye Res. 2010, 90 (1): 10-16. 10.1016/j.exer.2009.09.001.
Klein R, Klein BEK, Knudtson MD, Wong TY, Cotch MF, Liu K, Burke G, Saad MF, Jacobs DR: Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006, 113 (3): 373-380. 10.1016/j.ophtha.2005.12.013.
Loh FH, Khin LW, Saw SM, Lee JJM, Gu K: The age of menopause and the menopause transition in a multiracial population. A nation-wide singapore study. Maturitas. 2005, 52 (3-4): 169-180. 10.1016/j.maturitas.2004.11.004.
Asefzadeh B, Cavallerano AA, Fisch BM: Racial differences in macular thickness in healthy eyes. Optom Vis Sci. 2007, 84 (10): 941-945. 10.1097/OPX.0b013e318157a6a0.
Guedes V, Schuman JS, Hertzmark E, Wollstein G, Correnti A, Mancini R, Lederer D, Voskanian S, Velazquez L, Pakter HM, et al: Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003, 110 (1): 177-189. 10.1016/S0161-6420(02)01564-6.
Huynh SC, Wang XY, Rochtchina E, Mitchell P: Distribution of macular thickness by optical coherence tomography: Findings from a population-based study of 6-year-old children. Invest Ophthalmol Vis Sci. 2006, 47 (6): 2351-2357. 10.1167/iovs.05-1396.
Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV, Eliott DE, Haller JA, Nguyen QD: Retinal thickness analysis by race, gender, and age using stratus oct. Am J Ophthalmol. 2010, 149 (3): 496-502. 10.1016/j.ajo.2009.09.025.
Bjornsson OM, Syrdalen P, Bird AC, Peto T, Kinge B: The prevalence of age-related maculopathy (arm) in an urban norwegian population: The oslo macular study. Acta Ophthalmol Scand. 2006, 84 (5): 636-641. 10.1111/j.1600-0420.2006.00696.x.
Dratva J, Real FG, Schindler C, Ackermann-Liebrich U, Gerbase MW, Probst-Hensch NM, Svanes C, Omenaas ER, Neukirch F, Wjst M, et al: Is age at menopause increasing across europe? Results on age at menopause and determinants from two population-based studies. Menopause-J N Am Menopause Soc. 2009, 16 (2): 385-394.
Jacobsen BK, Heuch I, Kvale G: Age at natural menopause and all-cause mortality: A 37-year follow-up of 19,731 norwegian women. Am J Epidemiol. 2003, 157 (10): 923-929. 10.1093/aje/kwg066.
Jacobsen BK, Heuch I, Kvale G: Age at natural menopause and stroke mortality - cohort study with 3561 stroke deaths during 37-year follow-up. Stroke. 2004, 35 (7): 1548-1551. 10.1161/01.STR.0000131746.49082.5c.
Mikkelsen TF, Graff-Iversen S, Sundby J, Bjertness E: Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: A cross-sectional study. BMC Public Health. 2007, 7: 149-10.1186/1471-2458-7-149.
Sehi M, Guaqueta DC, Feuer WJ, Greenfield DS: A comparison of structural measurements using 2 stratus optical coherence tomography instruments. J Glaucoma. 2007, 16 (3): 287-292. 10.1097/IJG.0b013e3180391a72.
Wang XY, Huynh SC, Burlutsky G, Ip J, Stapleton F, Mitchell P: Reproducibility of and effect of magnification on optical coherence tomography measurements in children. Am J Ophthalmol. 2007, 143 (3): 484-488. 10.1016/j.ajo.2006.11.042.
Smith M, Frost A, Graham CM, Shaw S: Effect of pupillary dilatation on glaucoma assessments using optical coherence tomography. Br J Ophthalmol. 2007, 91 (12): 1686-1690. 10.1136/bjo.2006.113134.
Youm DJ, Kim JM, Park KH, Choi CY: The effect of soft contact lenses during the measurement of retinal nerve fiber layer thickness using optical coherence tomography. Curr Eye Res. 2009, 34 (1): 78-83. 10.1080/02713680802579188.
Barkana Y, Burgansky-Eliash Z, Gerber Y, Melamed S, Neudorfer M, Avni I, Bartov E, Morad Y: Inter-device variability of the stratus optical coherence tomography. Am J Ophthalmol. 2009, 147 (2): 260-266. 10.1016/j.ajo.2008.08.008.
Muscat S, Parks S, Kemp E, Keating D: Repeatability and reproducibility of macular thickness measurements with the humphrey oct system. Invest Ophthalmol Vis Sci. 2002, 43 (2): 490-495.
Lima-Gomez V, Ojeda-Cruz P: Concordance of two retinal mapping techniques to detect diabetic macular edema. Cir Cir. 2009, 77 (2): 83-87.
Liew SHM, Gilbert CE, Spector TD, Mellerio J, Van Kuijk FJ, Beatty S, Fitzke F, Marshall J, Hammond CJ: Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res. 2006, 82 (5): 915-920. 10.1016/j.exer.2005.10.014.
Chamberlain MD, Guymer RH, Dirani M, Hopper JL, Baird PN: Heritability of macular thickness determined by optical coherence tomography. Invest Ophthalmol Vis Sci. 2006, 47 (1): 336-340. 10.1167/iovs.05-0599.
Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS: Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol. 2006, 124 (2): 193-198. 10.1001/archopht.124.2.193.
Falsini B, Ziccardi L, Stifano G, Iarossi G, Merendino E, Minnella AM, Fadda A, Balestrazzi E: Temporal response properties of the macular cone system: Effect of normal aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2007, 48 (10): 4811-4817. 10.1167/iovs.07-0306.
Curcio CA, Millican CL, Allen KA, Kalina RE: Aging of the human photoreceptor mosaic - evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993, 34 (12): 3278-3296.
Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG: Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998, 105 (2): 360-370. 10.1016/S0161-6420(98)93601-6.
Lam DSC, Leung KS, Mohamed S, Chan WM, Palanivelu MS, Cheung CYL, Li EYM, Lai RYK, Leung CKS: Regional variations in the relationship between macular thickness measurements and myopia. Invest Ophthalmol Vis Sci. 2007, 48 (1): 376-382. 10.1167/iovs.06-0426.
Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccheri B, Fiore T, Maestranzi G: Macular thickness measured by optical coherence tomography (oct) in diabetic patients. Eur J Ophthalmol. 2002, 12 (6): 482-487.
Liew SHM, Gilbert CE, Spector TD, Marshall J, Hammond CJ: The role of heredity in determining central retinal thickness. Br J Ophthalmol. 2007, 91 (9): 1143-1147. 10.1136/bjo.2007.114215.
Wakitani Y, Sasoh M, Sugimoto M, Ito Y, Ido M, Uji Y: Macular thickness measurements in healthy subjects with different axial lengths using optical coherence tomography. Retina. 2003, 23 (2): 177-182. 10.1097/00006982-200304000-00007.
Wong ACM, Chan CWN, Hui SP: Relationship of gender, body mass index, and axial length with central retinal thickness using optical coherence tomography. Eye. 2005, 19 (3): 292-297. 10.1038/sj.eye.6701466.
Kelty PJ, Payne JF, Trivedi RH, Kelty J, Bowie EM, Burger BM: Macular thickness assessment in healthy eyes based on ethnicity using stratus oct optical coherence tomography. Invest Ophthalmol Vis Sci. 2008, 49 (6): 2668-2672. 10.1167/iovs.07-1000.
Huang JJ, Liu X, Wu ZQ, Xiao H, Dustin L, Sadda S: Macular thickness measurements in normal eyes with time-domain and fourier-domain optical coherence tomography. Retina. 2009, 29 (7): 980-987. 10.1097/IAE.0b013e3181a2c1a7.
Grunwald JE, Hariprasad SM, DuPont J: Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998, 116 (2): 150-154.
Provis JM: Development of the primate retinal vasculature. Prog Retin Eye Res. 2001, 20 (6): 799-821. 10.1016/S1350-9462(01)00012-X.
Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, Van Nieuwenhuyzen P, Hu P: Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: A model for cns aging. Microcirculation. 2007, 14 (1): 63-76. 10.1080/10739680601073451.
Hogg RE, Dimitrov PN, Dirani M, Varsamidis M, Chamberlain MD, Baird PN, Guymer RH, Vingrys AJ: Gene-environment interactions and aging visual function a classical twin study. Ophthalmology. 2009, 116 (2): 263-269. 10.1016/j.ophtha.2008.09.002.
Wolf-Schnurrbusch UEK, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf S: Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci. 2007, 48 (8): 3783-3787. 10.1167/iovs.06-1218.
El-Ashry M, Hegde V, James P, Pagliarini S: Analysis of macular thickness in british population using optical coherence tomography (oct). An emphasis on interocular symmetry. Curr Eye Res. 2008, 33 (8): 693-699. 10.1080/02713680802323140.
Grover S, Murthy RK, Brar VS, Chalam KV: Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol. 2009, 148 (2): 266-271. 10.1016/j.ajo.2009.03.006.
Wachnik A, Biro G, Biro L, Korom M, Gergely A, Antal M: Effect of sex-hormones on copper, zinc, iron nutritional-status and hepatic lipid-peroxidation in rats. Nahr-Food. 1993, 37 (1): 28-34. 10.1002/food.19930370106.
Yagi K, Komura S: Inhibitory effect of female hormones on lipid-peroxidation. Biochem Int. 1986, 13 (6): 1051-1055.
Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE: Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst. 1985, 74 (4): 741-745.
Byrnes EM, Babb JA, Bridges RS: Differential expression of oestrogen receptor alpha following reproductive experience in young and middle-aged female rats. J Neuroendocrinol. 2009, 21 (6): 550-557. 10.1111/j.1365-2826.2009.01874.x.
Bridges RS, Byrnes EM: Reproductive experience reduces circulating 17beta-estradiol and prolactin levels during proestrus and alters estrogen sensitivity in female rats. Endocrinology. 2006, 147 (5): 2575-2582. 10.1210/en.2005-0917.
de Kleijn MJ, Schouw van der YT, Graaf van der Y: Reproductive history and cardiovascular disease risk in postmenopausal women: A review of the literature. Maturitas. 1999, 33 (1): 7-36. 10.1016/S0378-5122(99)00038-9.
Stein DM, Wollstein G, Ishikawa H, Hertzmark E, Noecker RJ, Schuman JS: Effect of corneal drying on optical coherence tomography. Ophthalmology. 2006, 113 (6): 985-991. 10.1016/j.ophtha.2006.02.018.
Wu ZQ, Huang JJ, Dustin L, Sadda SR: Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma. 2009, 18 (3): 213-216. 10.1097/IJG.0b013e31817eee20.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2415/10/13/prepub
We thank all colleagues at St. Olavs University Hospital for their effort volunteering for OCT measurements and disclosing relevant health related information for the study. This study would not be possible without the administrative support from the head of Department of Ophthalmology, Dr Kjell-Morten Møen and Mrs. Guri Helene Broum Olsen. We acknowledge the contribution of Mrs. Ingrid Riphagen, Unit for Applied Clinical Research, Norwegian University of Science and Technology for managing literature references.
The authors declare that they have no competing interests.
TBE suggested the initial concept and together with AW was responsible for planning the study design. AW carried out the data collection including OCT measurements. TS helped with the statistical analysis and interpretation. All authors have participated in the writing and approval of the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Wexler, A., Sand, T. & Elsås, T.B. Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study. BMC Ophthalmol 10, 13 (2010). https://doi.org/10.1186/1471-2415-10-13
- Optical Coherence Tomography
- Retinal Nerve Fiber Layer
- Macular Hole
- Nulliparous Woman
- Macular Thickness